openPR Logo
Press release

Global Impact of Covid-19 on Pharmacogenomics (PGx) Market to Record Significant Revenue Growth During the Forecast Period 2020–2027 | Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., etc

10-02-2020 08:05 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Report And Data

Pharmacogenomics (PGx) Market

Pharmacogenomics (PGx) Market

Industry Analysis of Pharmacogenomics (PGx) Market

The Global Pharmacogenomics (PGx) Market report gives a comprehensive overview of the Pharmacogenomics (PGx) market scenario to present accurate forecasts of the upcoming years with special focus on the competitive landscape, market segmentation, current, and emerging trends, and strategic recommendations to help readers gain a robust footing in the market. The report also focuses on the comprehensive analysis of the competitive landscape along with descriptive company profiles, market share, product portfolio, financial standings, market reach, global position, and strategic business expansion plans. The global Pharmacogenomics (PGx) market is forecasted to grow at a rate of 8.7% from USD 5.66 billion in 2018 to USD 11.01 billion in 2027.

The report is furnished with the latest market scenario pertaining to the COVID-19 pandemic and its after-effects on the Pharmacogenomics (PGx) industry and the key segments. The pandemic has disrupted the workflow of the industry and created financial difficulties. The report assesses the complete impact of the pandemic on the market and offers key insights into the market scenario along with trends and demands disruptions. The report also offers an outlook on the market scenario in the forecast timeline.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2296

Some of the players profiled in the report are Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporation of America Holdings and others.

The Global Pharmacogenomics (PGx) Market is segmented as follows:

Products and Services Outlook (Revenue, USD Billion; 2017-2027)
Products
Kits
Assay & Reagents
Instruments
Software
Services
Genotyping
SNP Identification
Pharmacogenetics Testing
Other Services

Technology Outlook (Revenue, USD Billion; 2017-2027)
Polymerase Chain Reaction (PCR)
Real Time PCR
qPCR
Digital PCR
DNA Sequencing/Next Generation Sequencing (NGS)
Nucleic Acid Amplification Tests (NAATs)
Mass Spectrometry
Gel Electrophoresis
Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Others
Microarray
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Infectious Diseases
Neurology/Psychiatry
Cardiovascular
Others

End Use Outlook (Revenue, USD Billion; 2017-2027)
Research Organisation
Pharmaceutical Companies
Diagnostic Centers
Others

Market Segmentation by Regions:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2296

Key Point Summary of the Report:
The global Pharmacogenomics (PGx) market research report is an investigative study offering key insights into the latest growth trends, developments, technological and product advancements, and the research and development scenario. The report also covers the market aspects that directly influence the growth of the market. These features include strategies undertaken by the prominent players, their expansion tactics, and the product portfolios of the companies, and micro and macro-economic factors.

The study also analyses the crucial market aspects, including R&D, product launches and brand promotions, mergers and acquisitions, collaborations, joint ventures, and the growth pattern on both regional and global levels. The report offers an in-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/pharmacogenomics-pgx-market

To summarize everything stated above, the report offers key insights into the Pharmacogenomics (PGx) market to allow the reader to gain a complete understanding of the Global Pharmacogenomics (PGx) Market through accurate estimations, a panoramic view of the market scenario, competitive landscape, factors influencing the growth of the market, driving factors, restraints, regulatory framework, growth prospects, and opportunities, and factors propelling the market forward. The research study offers an in-depth view of the industry to offer a competitive edge to the reader and help them in formulating beneficial investment plans. The report provides a comprehensive overview of the market with facts relating to the past, present, and future of the Global Pharmacogenomics (PGx) Market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2296

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or queries about customization options, please reach out to us, and we will offer you the report best suited for your needs.

40 Wall St. 28th floor New York City, NY 10005 United States

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Impact of Covid-19 on Pharmacogenomics (PGx) Market to Record Significant Revenue Growth During the Forecast Period 2020–2027 | Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., etc here

News-ID: 2148430 • Views:

More Releases from Report And Data

Medical Tourism Market to Register Rapid Growth Due to High-Quality Services in Developing Nations and Rising Healthcare Expenses
Medical Tourism Market to Register Rapid Growth Due to High-Quality Services in …
The Medical Tourism Market is divided into several segments based on type of treatment outlook and patient type outlook. In terms of the type of treatment outlook, the market is segmented into cosmetic, dental, cardiovascular, orthopedic, and others. The cosmetic segment is expected to witness significant growth due to the increasing demand for plastic surgery, breast implants, and other cosmetic procedures. The dental segment is also expected to grow rapidly
Labradorite Market Analysis By Future Demand, Top Players, and Growth Rate Through 2030
Labradorite Market Analysis By Future Demand, Top Players, and Growth Rate Throu …
Labradorite Market Overview: The labradorite market has experienced significant growth in 2021 and is projected to continue with a high CAGR in the coming years. One of the primary drivers of this growth is the increasing utilization of labradorite in the glass-making industry. Its high reflectivity makes it a popular choice for glazes and mosaics, while its granular structure and strength have resulted in its adoption in the road construction sector. Labradorite
Automotive Electronics/Electrical E/E Architecture Market to Reflect Tremendous Growth Potential with A CAGR of 9.3% BY 2032
Automotive Electronics/Electrical E/E Architecture Market to Reflect Tremendous …
Automotive Electronics/Electrical E/E Architecture Market Overview The market size of the global automotive Electronics/Electrical (E/E) architecture was USD 40.33 billion in 2022 and is predicted to reach USD 90 billion in 2032. The revenue of the market is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 9.3% during the projected period, driven by the increasing demand for Advanced Driver Assistance Systems (ADAS), connected vehicles, and electric cars. The fast
Catalyst Fertilizers Market Will Generate All New Growth Opportunities, Projected To Reach USD 4.78 Billion At a CAGR of 2%
Catalyst Fertilizers Market Will Generate All New Growth Opportunities, Projecte …
Catalyst Fertilizers Market Overview: The catalyst fertilizers market is projected to grow significantly during the forecast period, with the market size expected to increase from USD 3.12 Billion in 2022 to USD 4.78 Billion in 2032, indicating a rapid revenue CAGR of 2%. This growth is primarily driven by the increasing demand for food due to the rising population, which has resulted in a need for efficient and high-yielding crop production.

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics Market Is Booming Worldwide 2022-2028
Another factual information on the ""Pharmacogenomics Market"" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall industry, drivers, restrictions, opportunities. It gives an investigative view to settle on further choices in organizations. It covers comprehensive instructive information of various key players working over the globe. Get PDF Brochure
Pharmacogenomics Market || Global Forecast and Analysis 2020-2030
The study of Pharmacogenomics Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. Also this
Pharmacogenomics Market Size & Share Expanding Across the Globe
Allied Market Research published a report, titled, "Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Opportunity Analysis and Industry Forecast, 2017 – 2025." The report provides a comprehensive analysis of top investment pockets, drivers & opportunities, major
Pharmacogenomics Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pharmacogenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html   Pharmacogenomics is the study of the role of the
Pharmacogenomics Market Analysis, Forecast, and Assessment 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individual’s genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses that
Pharmacogenomics Market : Share, Analysis To 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individual’s genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses that